Form 4 for NVCR NovoCure Ltd
Accepted 2026-03-05 00:00:00 ET · period of report 2026-03-03 · accession 0001917165-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-05 | 2026-03-03 | NVCR | Ben Arye Barak | GC | A - Grant | $0.00 | +50.1K | 242.5K | +26% | $0 |
| D | 2026-03-05 | 2026-03-03 | NVCR | Ben Arye Barak | GC | A - Grant | $0.00 | +73.3K | 73.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-03-03 | A | A | 50,125 | $0.00 | 242,453 | D | — | — | (F1) Represents restricted share units that are scheduled to vest in equal parts on the first, second and third anniversary of the grant date, subject to the reporting person's continued employment through such dates. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-03-03 | A | A | 73,340 | $0.00 | 73,340 | D | $13.30 · — to 2036-03-03 | 73,340 Ordinary Shares | (F2) Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date. |